Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antihypertensive therapy and atherosclerosis.

M J Horan1

  • 1National Heart, Lung, and Blood Institute, Division of Heart and Vascular Diseases, Bethesda, MD 20892.

The American Journal of the Medical Sciences
|June 1, 1991
PubMed
Summary

Effective hypertension management for cardiovascular disease requires addressing both blood pressure and lipid metabolism. Certain antihypertensive drugs impact lipids, necessitating careful selection for patients with atherosclerosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential diagnosis in obscure fever.

The American journal of medicine·2010
Same author

Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991.

Hypertension (Dallas, Tex. : 1979)·1995
Same author

Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.

Hypertension (Dallas, Tex. : 1979)·1995
Same author

Changes in hypertension awareness, treatment, and control rates. 20-year trend data.

Annals of epidemiology·1993
Same author

Relation of site of acute myocardial infarction to the site of maximal coronary narrowing.

The American journal of cardiology·1993
Same author

The heart in hypertension.

The New England journal of medicine·1992

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Metabolic Disorders

Background:

  • Hypertension and atherosclerosis are key contributors to cardiovascular disease pathogenesis.
  • Some antihypertensive drugs, like diuretics and beta adrenergic blockers, can negatively affect lipid metabolism.
  • Other antihypertensive classes generally do not exhibit adverse lipid effects.

Purpose of the Study:

  • To recommend a vascular biological approach for managing patients with both hypertension and atherosclerosis.
  • To highlight the importance of selecting antihypertensive agents that do not adversely affect lipid metabolism.
  • To emphasize the dual treatment strategy for blood pressure and lipid disorders.

Main Methods:

  • Review of existing literature on antihypertensive medications and their effects on lipid metabolism.

Related Experiment Videos

  • Analysis of animal model studies investigating the anti-atherogenic effects of various drug classes.
  • Synthesis of findings to propose a therapeutic strategy.

    • Main Results:

    • Diuretics and beta adrenergic blockers can have adverse effects on lipid profiles.
    • Beta adrenergic blockers, angiotensin converting enzyme (ACE) inhibitors, and calcium antagonists demonstrated anti-atherogenic effects in animal models.
    • A combined approach targeting both blood pressure and lipid disorders is beneficial.

    Conclusions:

    • A vascular biological approach is recommended for patients with comorbid hypertension and atherosclerosis.
    • Prioritize blood pressure reduction using agents with neutral or beneficial effects on lipid metabolism.
    • Simultaneous treatment of lipid metabolism disorders is crucial for comprehensive cardiovascular care.